Wells Fargo’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

Wells Fargo’s Portfolio AVNR Stock Details AVNR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-35,179	Closed	-$597K	–	6658
2014 Q4	$597K	Sell	35,179 -41,475	-54%	-$583K	﹤0.01%	3853
2014 Q3	$914K	Sell	76,654 -1,440	-2%	-$9.83K	﹤0.01%	3529
2014 Q2	$440K	Buy	78,094 +7,554	+11%	+$34.8K	﹤0.01%	3985
2014 Q1	$259K	Sell	70,540 -11,148	-14%	-$42.5K	﹤0.01%	4220
2013 Q4	$275K	Buy	81,688 +57,502	+238%	+$237K	﹤0.01%	4093
2013 Q3	$102K	Sell	24,186 -1,765	-7%	-$8.36K	﹤0.01%	4463
2013 Q2	$120K	Buy	+25,951	New	+$89.2K	﹤0.01%	4336

Wells Fargo's AVNR Position: Q1 2015 in Review

Wells Fargo sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q1 2015, closing a stake of 35,179 shares — an estimated $597K sold.

Wells Fargo first reported a position in AVNR in Q2 2013 and held it in 7 quarters. The position peaked at $914K in Q3 2014. 0 funds tracked by Wall St. Rank hold AVNR as of Q1 2015.

Wells Fargo reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q1 2015 after selling out during the quarter.
Wells Fargo sold 35,179 AVANIR PHARMACEUTICALS, INC CL A shares in Q1 2015, an estimated $597K.
Wells Fargo first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q2 2013 and held it in 7 quarters.
Wells Fargo's AVANIR PHARMACEUTICALS, INC CL A position peaked at $914K in Q3 2014.
0 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q1 2015.

Based on Wells Fargo's 13F filing for Q1 2015, filed 12 May 2015.